6:46 PM
 | 
May 30, 2013
 |  BC Extra  |  Top Story

Epizyme raises $77 million in IPO

Cancer company Epizyme Inc. (NASDAQ:EPZM) raised $77.1 million in an IPO on Thursday through the sale of more shares than it had proposed last week at the upper end of its proposed range. The company...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >